Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis

Journal of Clinical Microbiology

Volumn 37, Issue 2, 1999, Pages 304-309

  Williams, Stephanie L ^a   Harris, N Beth ^a   Barletta, Raúl G ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4.3.0]NON 8 YL) 6 FLUORO 1,4 DIHYDRO 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMIKACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LUCIFERASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BIOLUMINESCENCE; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; PARATUBERCULOSIS; PRIORITY JOURNAL;

EID: 0032923674     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.2.304-309.1999     Document Type: Article

References (36)

1. Arain, T. M., A. E. Resconi, D. C. Singh, and C. K. Stover. 1996. Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob. Agents Chemother. 40:1542-1544.
2. Arain, T. M., A. E. Resconi, M. J. Hickey, and C. K. Stover. 1996. Bioluminescence screening in vitro (Bio-SiV) assays for high-volume antimycobacterial drug discovery. Antimicrob. Agents Chemother. 40:1536-1541.
3. Bauernfeind, A. 1993. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin. tosufloxacin. CI-960 and CI-990. J. Antimicrob. Chemother. 31:505-522.
4. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, L. Barbara-Burnham, and L. S. Young. 1996. Activities of Bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice. Antimicrob. Agents Chemother. 40:546-551.
5. Chiodini, R. J., H. J. Van Kruiningen, and R. S. Merkal. 1984. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet. 74:218-262.
6. Chiodini, R. J., H. J. Van Kruiningen, R. S. Merkal, W. R. Thayer, and J. A. Coutu. 1984. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J. Clin. Microbiol. 20:966-971.
7. Chiodini, R. J., H. J. Van Kruiningen, W. R. Thayer, J. A. Coutu, and R. S. Merkal. 1984. In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease. Antimicrob. Agents Chemother. 26:930-932.
8. Chiodini, R. J. 1986. Biochemical characteristics of various strains of Mycobacterium paratuberculosis. Am. J. Vet. Res. 47:1442-1445.
9. Chiodini, R. J., and H. J. Van Kruiningen. 1986. The prevalence of paratuberculosis in culled New England cattle. Cornell Vet. 76:91-104.
10. Chiodini, R. J. 1990. Bactericidal activities of various antimicrobial agents against human and animal isolates of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34:366-367.
11. Cocito, C., P. Gilot, M. Coene, M. de Kesel, P. Poupart, and P. Vannuffel. 1994. Paratuberculosis. Clin. Microbiol. Rev. 7:328-345.
12. Collins, M. T., D. C. Sockett, and W. J. Goodger. 1992. Herd prevalence, geographic distribution and risk factors for bovine paratuberculosis in Wisconsin. J. Am. Vet. Med. Assoc. 187:323-329.
13. Collins, M. T., D. C. Sockett, W. J. Goodger, T. A. Conrad, C. B. Thomas, and D. J. Carr. 1994. Herd prevalence and geographic distribution of, and risk factors for, bovine paratuberculosis in Wisconsin. J. Am. Vet. Med. Assoc. 204:636-641.
14. Cooksey, R. C., J. T. Crawford, W. R. Jacobs, Jr., and T. M. Shinnick. 1993. A rapid method for screening antimicrobial agents for activities against a strain of Mycobaceterium tuberculosis expressing firefly luciferase. Antimicrob. Agents Chemother. 37:1348-1352.
15. Cooksey, R. C., G. P. Morlock, M. Beggs, and J. T. Crawford. 1995. Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob. Agents Chemother. 39:754-756.
16. Fattorini, L., V. Xiao, M. Mattei, Y. Li, E. Iona, M. L. Ricci, O. F. Thorensen, R. Creti, and G. Oreflci. 1998. Activities of isoniazid alone and in combination with other drugs against Mycobacterium avium infection in beige micc. Antimicrob. Agents Chemother. 42:712-714.
17. Foley-Thomas, E. M., D. L. Whipple, L. E. Bermudez, and R. G. Barletta. 1995. Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis. Microbiology 141:1173-1181.
18. Gezon, H. M., H. D. Bither, H. C. Gibbs, E. J. Acker, L. A. Hanson, J. K. Thompson, and R. D. Jorgenson. 1988. Identification and control of paratuberculosis in a large goat herd. Am. J. Vet. Res. 49:1817-1823.
19. Hickey, M. J., T. M. Arain, R. M. Shawar, D. J. Humble, M. H. Langhorne, J. N. Morgenroth, and C. K. Stover. 1996. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40:400-407.
20. Jacobs, W. R., Jr., R. G. Barletla, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Kieser, G. J. Sarkis, G. F. Hatfull, and B. R. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
21. Mishina, D., P. Katsel, S. T. Brown, E. C. A. M. Gilberts, and R. J. Greenstein. 1996. On the etiology of Crohn disease. Proc. Natl. Acad. Sci. USA 93: 9816-9820.
22. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. Prescott, J. F., and J. D. Baggot. 1993. Antimicrobial therapy in veterinary medicine, p. 288-289. Iowa State University Press, Ames.
24. Rastogi, N., K. S. Goh, and V. Labrousse. 1992. Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. Antimicrob. Agents Chemother. 36:2843-2846.
25. Rastogi, N., V. Labrousse, and J. S. Goh. 1996. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr. Microbiol. 33:167-175.
26. Schmidt, U., and G. Schluter. 1996. Studies on the mechanism of phototoxicity of Bay y 3118 and other quinolones. Adv. Exp. Med. Biol. 387;117-120.
27. Shawar, R. M., D. J. Humble, J. M. Van Dalfsen, C. K. Stover, M. J. Hickey, S. Steele, L. A. Mitscher, and W. Baker. 1997. Rapid screening of natural products for antimycobaclerial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob. Agents Chemother. 41:570-574.
28. Sirgel, F. A., A. Venter, and H.-D. Heilmann. 1995. Comparative in-vitro activity of Bay y 3118, a new quinolone. and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. J. Antimicrob. Chemother. 35:349-357.
29. St.-Jean, G., and A. D. Jernigan. 1991. Treatment of Mycobacterium paratuberculosis infection in ruminants. Vet. Clin. N. Am. Food Anim. Pract. 7: 793-804.
30. St.-Jean, G. 1996. Treatment of clinical paratuberculosis in cattle. Vet. Clin. N. Am. Food Anim. Pract. 12:417-430.
31. Thompson, D. E. 1994. The role of mycobacteria in Crohn's disease. J. Med. Microbiol. 41:74-94.
32. Thorel, M.-F., M. Krichevsky, and V. V. Levy-Frebault. 1990. Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int. J. Syst. Bacteriol. 40: 254-260.
33. Van Boxtel, R. M., R. S. Lambrecht, and M. T. Collins. 1990. Effects of colonial morphology and Tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34:2300-2303.
34. Wallace, R. J., D. R. Nash, L. C. Steele, and V. Steingrube. 1986. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol. 24:976-981.
35. Wilson, D. J., C. A. Rossiter, H. R. Han, and P. M. Sears. 1996. Financial effects of Mycobacterium paratuberculosis on mastitis, culling and milk production in clinically normal dairy cattle, p. 151-158. In R. J. Chiodini, E. E. Mines II, and M. T. Collins (ed.). Proceedings of the Fifth International Colloquium on Paratuberculosis. International Association for Paratuberculosis, Inc., Madison, Wis.
36. Yamori, S., and M. Tsukamura. 1991. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol. Immunol. 35:921-926.